Beximco Pharma (BXP.L): Third quarter results for 2020 | Silence Therapeutics (SLN.L): Business update
23 Jun 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP:LON), 37.0 | Silence Therapeutics plc (SLNCF:OTC), 0
- Published:
23 Jun 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Beximco Pharma (BXP.L): Third quarter results for 2020 | Silence Therapeutics (SLN.L): Business update